Skip to Main Content
Bora Acquires Pyros Pharmaceuticals to Bolster Upsher-Smith Rare Disease Product Portfolio
Upsher-Smith Laboratories, LLC
Home
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
News
Plant C
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
800-654-2299
Capabilities
Products
Products A-Z
Our Brands
Product Patents
Corporate Development
Corporate Development
NASPA Innovation Map
About Us
About Upsher-Smith
History
Executive Team
Awards
Charitable Activity
Policies
Careers
Careers at Upsher-Smith
Company Culture
Manufacturing
Military
Students & Interns
Contact Us
Contact Upsher-Smith
Locations
Plant C
News
800-654-2299
Sawai Financial Summary for the Second Quarter of FY2022
November 8, 2022
Company News
Share:
Share on Facebook
Share on Twitter
Share on LinkedIn
Share via Email
Link
Upsher-Smith Expands Haloperidol Product Family to Include Unit Dose Tablets
Sawai Presentation: FY2022 Financial Results for the 1st Half
Careers
Join Our Team!
We’re hiring
Search Our Jobs
Close
